Dara Biosciences (DARA +20.7%) regains yesterday's upward move plus more after saying it's...

|By:, SA News Editor

Dara Biosciences (DARA +20.7%) regains yesterday's upward move plus more after saying it's signed an exclusive agreement with The Helsinn Group of Switzerland for the U.S. commercial rights to Gelclair. Gelclair is an FDA-cleared topical gel topical gel used to reduce pain from oral mucositis.